SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Should We Consider Intradermal Vaccination?

J Am Soc Nephrol. 2022 Apr;33(4):869-870. doi: 10.1681/ASN.2021121566. Epub 2022 Feb 14.

Authors

Veerle Wijtvliet¹, Karl Martin Wissing², Daniel Abramowicz¹, Kristien J Ledeganck¹

Affiliations

¹ Department of Nephrology and Hypertension, Antwerp University Hospital, Edegem, Belgium.
² Department of Nephrology, Universitair Ziekenhuis Brussel, Brussels, Belgium.

No abstract available

Keywords: COVID-19; COVID-19 vaccines; SARS-CoV-2; T lymphocytes; intradermal vaccination; kidney transplant recipients; third dose.

Publication types

Letter
Comment

MeSH terms

Antibodies, Viral
COVID-19 Vaccines
COVID-19* / prevention & control
Humans
Kidney Transplantation*
SARS-CoV-2
Transplant Recipients
Vaccination

Substances

Antibodies, Viral
COVID-19 Vaccines